Jun 15, 2023 / 05:40PM GMT
Unidentified Analyst
For our last session of the day, thanks so much to the team from IDEAYA Biosciences for joining us. Maybe just quickly an introduction from both of you. And if you could, a brief overview (technical difficulty) today and with respect to what your value drivers are.
Yujiro Hata - IDEAYA Biosciences, Inc. - President & CEO
Sure. Well, first, thank you so much, Karen, for the kind invitation to participate this year. Yujiro Hata, President and CEO. I can maybe let Darrin do a quick introduction as well, and I'm happy to go through a quick overview.
Darrin Beaupre - IDEAYA Biosciences, Inc. - Chief Medical Officer
Yeah. Hi, I am Darrin Beaupre. I'm the Chief Medical Officer at IDEAYA Biosciences. I've been with the company for about seven or eight months now. My background is I'm a medical oncologist, hematologist, PhD in cancer biology. Started out at the Moffitt Cancer Center, but I've been in the industry 16 years. Joined IDEAYA because of an amazing pipeline that you're going to hear about.
IDEAYA Biosciences Inc at Goldman Sachs Healthcare Conference Transcript
Jun 15, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers